US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Bayer A.G.

12.02

+0.22001.86%

Volume:1.89M

Turnover:22.66M

Market Cap:47.23B

PE:-11.11

High:12.12

Open:12.07

Low:11.97

Close:11.80

52wk High:14.85

52wk Low:5.84

Shares:3.93B

Float Shares:3.93B

Volume Ratio:1.29

T/O Rate:0.05%

Dividend:0.03

Dividend Rate:0.26%

EPS(TTM):-1.0816

EPS(LYR):-0.6723

ROE:-12.37%

ROA:2.97%

PB:1.55

PE(LYR):-17.88

Loading ...

Overview Company News Filings

Bayer’s TARA Study: Real‑World Prostate Cancer Data That Could Shape BAYRY’s Outlook

Bayer’s FIRST-2.0 China Study: Real-World Kidney Data That Could Matter for BAYRY

Bayer upgraded to Hold from Sell at DZ Bank

Bayer says Europe may need to pay more for medicines, FT reports

Dow Jones Top Company Headlines at 11 AM ET: Conagra Brands Narrows Outlook on Mixed Results | Intel ...

Bayer Pharma Head Touts Healthiest Pipeline in Company's History -- Market Talk

Bayer appoints Nelson Ambrogio as president of U.S. pharmaceuticals

Jeff Ubben's Inclusive Capital Sells $369 Million in Bayer Stock

Bayer Edging Closer to Litigation Resolution -- Market Talk

Bayer price target lowered to EUR 53 from EUR 55 at Morgan Stanley

Bayer's Roundup Settlement Isn't a Done Deal Yet -- Market Talk

Dow Jones Top Company Headlines at 5 PM ET: Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback as AI Demand Climbs | Ford ...

Court preliminary approves Bayer’s Roundup settlement, Bloomberg says

Bayer Expects Farmers to Plant Less Corn, More Soybeans After Fertilizer Price Spike -- Market Talk

Bayer gets FDA clearance of Medrad MRXperion Magnetic Resonance Injection System

Bayer Sees Pharma Business Turning a Corner -- Market Talk

Bayer Expects Consumer Sales to Remain Under Pressure in U.S., China -- Market Talk

Bayer Expects Challenging Agriculture Market in 2026 -- Market Talk

Bayer Q4 Adj. EPS $0.18 Down From $0.28 YoY, Sales $13.316B Up From $12.518B YoY

Bayer Beats Expectations, But Currency Headwinds Cloud Outlook -- Market Talk

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BAYRY/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BAYRY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BAYRY\",,,,,undefined,":{"symbol":"BAYRY","market":"US","secType":"STK","nameCN":"Bayer A.G.","latestPrice":12.02,"timestamp":1776456000000,"preClose":11.8,"halted":0,"volume":1885074,"delay":15,"changeRate":0.018644067796610073,"floatShares":3929259738,"shares":3929696328,"eps":-1.081596,"marketStatus":"Market Closed","change":0.22,"latestTime":"04-17 16:00:00 EDT Delay","open":12.07,"high":12.1248,"low":11.9701,"amount":22655565.988083977,"amplitude":0.01311,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-1.081596,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776672000000},"marketStatusCode":7,"adr":0,"adrRate":0.25,"exchange":"OTCQX","adjPreClose":11.8,"volumeRatio":1.291558},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BAYRY\",,,,,undefined,":{"symbol":"BAYRY","floatShares":3929259738,"roa":"2.97%","roe":"-12.37%","lyrEps":-0.672343,"volumeRatio":1.291558,"shares":3929696328,"dividePrice":0.0316,"high":12.1248,"amplitude":0.01311,"preClose":11.8,"low":11.9701,"week52Low":5.84,"pbRate":"1.55","psRate":"0.88","week52High":14.85,"institutionHeld":0.0018,"latestPrice":12.02,"eps":-1.081596,"divideRate":0.002629,"volume":1885074,"delay":15,"ttmEps":-1.081596,"open":12.07,"prevYearClose":10.82,"prevWeekClose":11.75,"prevMonthClose":11.48,"prevQuarterClose":11.48,"fiveDayClose":11.75,"twentyDayClose":11.1475,"sixtyDayClose":12.68,"earningDate":1778515200000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BAYRY\",params:#limit:5,,,undefined,":[{"date":"2026-05-12","symbol":"BAYRY","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1778572800000,"name":null,"time":"","dateTimestamp":1778558400000,"actualEps":null},{"date":"2026-04-28","symbol":"BAYRY","amount":0.031526,"announcedDate":"2026-04-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-28","defaultRemindTime":1777383000000,"name":"Bayer A.G.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-11","payableDate":"2026-04-28","currency":"USD","dateTimestamp":1777348800000,"payDate":"2026-05-11"},{"market":"US","date":"2025-05-13","symbol":"BAYRY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"","actualEps":null},{"date":"2025-04-29","symbol":"BAYRY","amount":0.030365,"announcedDate":"2025-04-04","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-29","defaultRemindTime":1745933400000,"name":"Bayer A.G.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-12","payableDate":"2025-04-29","currency":"USD","dateTimestamp":1745899200000,"payDate":"2025-05-12"},{"market":"US","date":"2024-11-12","symbol":"BAYRY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BAYRY\",market:\"US\",,,undefined,":[{"executeDate":"2016-04-27","recordDate":"2016-04-29","paymentDate":"2016-05-12","value":2.091196,"currency":"USD"},{"executeDate":"2019-04-29","recordDate":"2019-04-30","paymentDate":"2019-05-13","value":0.550569,"currency":"USD"},{"executeDate":"2020-04-29","recordDate":"2020-04-30","paymentDate":"2020-05-14","value":0.535933,"currency":"USD"},{"executeDate":"2021-04-28","recordDate":"2021-04-29","paymentDate":"2021-05-10","value":0.407111,"currency":"USD"},{"executeDate":"2022-05-02","recordDate":"2022-05-03","paymentDate":"2022-05-16","value":0.549114,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BAYRY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.3333,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":3,"updateTime":1763092800000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BAYRY\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2628177282","title":"Bayer’s TARA Study: Real‑World Prostate Cancer Data That Could Shape BAYRY’s Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2628177282","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628177282?lang=en_us&edition=fundamental","pubTime":"2026-04-17 00:33","pubTimestamp":1776357223,"startTime":"0","endTime":"0","summary":"Bayer AG ($BAYRY) announced an update on their ongoing clinical study. Bayer (BAYRY) is running an Australian study called “Treatment Patterns and ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bayers-tara-study-real‑world-prostate-cancer-data-that-could-shape-bayrys-outlook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bayers-tara-study-real‑world-prostate-cancer-data-that-could-shape-bayrys-outlook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BAYRY","BK4139","TARA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627742355","title":"Bayer’s FIRST-2.0 China Study: Real-World Kidney Data That Could Matter for BAYRY","url":"https://stock-news.laohu8.com/highlight/detail?id=2627742355","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627742355?lang=en_us&edition=fundamental","pubTime":"2026-04-15 00:30","pubTimestamp":1776184228,"startTime":"0","endTime":"0","summary":"Bayer AG ($BAYRY) announced an update on their ongoing clinical study. The FIRST-2.0 China study, officially titled “Finerenone FIRST (Finerenone R...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bayers-first-2-0-china-study-real-world-kidney-data-that-could-matter-for-bayry?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bayers-first-2-0-china-study-real-world-kidney-data-that-could-matter-for-bayry?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BAYRY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626891193","title":"Bayer upgraded to Hold from Sell at DZ Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2626891193","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626891193?lang=en_us&edition=fundamental","pubTime":"2026-04-10 16:50","pubTimestamp":1775811035,"startTime":"0","endTime":"0","summary":"DZ Bank analyst Peter Spengler upgraded Bayer (BAYRY) to Hold from Sell with a EUR 44 price target Published first on TheFly – the ultimate source ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-upgraded-to-hold-from-sell-at-dz-bank-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-upgraded-to-hold-from-sell-at-dz-bank-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BAYRY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624237517","title":"Bayer says Europe may need to pay more for medicines, FT reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2624237517","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624237517?lang=en_us&edition=fundamental","pubTime":"2026-04-01 23:25","pubTimestamp":1775057149,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) has warned that Europe may need to pay higher drug prices to remain an attractive market for innovative medicines, arguing the long-s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-says-europe-may-need-to-pay-more-for-medicines-ft-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-says-europe-may-need-to-pay-more-for-medicines-ft-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BAYRY","BK4007","FT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624251293","title":"Dow Jones Top Company Headlines at 11 AM ET: Conagra Brands Narrows Outlook on Mixed Results | Intel ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2624251293","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624251293?lang=en_us&edition=fundamental","pubTime":"2026-04-01 23:00","pubTimestamp":1775055600,"startTime":"0","endTime":"0","summary":"Conagra Brands narrowed its outlook for the year after mixed results in its fiscal third quarter, as the food-and-snacks company continues to operate in a dynamic environment.Intel to Buy Apollo's Stake in Joint Ireland Chip Manufacturing Facility for $14.2 Billion. Intel agreed to buy Apollo Global Management's 49% stake in the companies' Fab 34 joint venture chip manufacturing plant in Ireland for $14.2 billion.Nike's Road to Recovery in China Is Hitting New Hurdles. The sneaker maker is losing ground in its second biggest market and warns that the next quarter there could be worse.Bayer Weighs U.S. Pharma Expansion as Turnaround Picks Up Speed. The company is looking at expanding its manufacturing footprint in the U.S., the head of its pharma unit said, turning to the world's largest drug market to drive a turnaround.Anthropic Races to Contain Leak of Code Behind Claude AI Agent. The developer has issued a copyright takedown request in bid to prevent competitors from cloning coding ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4602","LU2089985449.USD","LU0274383776.USD","BK4612","IE000M9KFDE8.USD","BK4533","BK4512","BIDU","BK4590","LU2148611432.USD","BK4605","CAG","BK4585","NKE","BK4515","BK4141","CALM","BK4579","LINT","BK4588","04335","INTW","BAYRY","BK4534","BK4543","BK4550","IE00BMQBXF63.USD","BK4527","LU2543165471.USD","LU0081259029.USD","LU0321505868.SGD","BK4144","IE00BZ18W340.USD","LU2931357623.SGD","INTC","BK4535","BK4575","MSFT","BK4561","LU0097036916.USD","09888","LU0321505439.SGD","BK4554","BK4581","BK4529","IE00BZ18W456.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624149975","title":"Bayer Pharma Head Touts Healthiest Pipeline in Company's History -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2624149975","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624149975?lang=en_us&edition=fundamental","pubTime":"2026-04-01 22:24","pubTimestamp":1775053440,"startTime":"0","endTime":"0","summary":"1423 GMT - Bayer's pharmaceutical division is set to benefit in coming years from a drug pipeline that is in better shape than ever before, the unit's president Stefan Oelrich says in an interview. \"Last year alone we had five product approvals and we had six phase three readouts,\" Oelrich says. A few years ago people said Bayer had no pharma pipeline, he adds. \"We've done a lot with relatively little.\" Oelrich cites a targeted radiotherapy for prostate cancer, gene therapies for Parkinson's disease and heart failure, and antibody for acute stroke among the most promising products in the business's early-stage pipeline. Shares rise 0.9%. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Bayer Pharma Head Touts Healthiest Pipeline in Company's History -- Market Talk","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624853572","title":"Bayer appoints Nelson Ambrogio as president of U.S. pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2624853572","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624853572?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:42","pubTimestamp":1774971778,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) announced a leadership change within its Pharmaceuticals’ Worldwide Markets organization. Effective May 1, Nelson Ambrogio, currently...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-appoints-nelson-ambrogio-as-president-of-u-s-pharmaceuticals-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-appoints-nelson-ambrogio-as-president-of-u-s-pharmaceuticals-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621064004","title":"Jeff Ubben's Inclusive Capital Sells $369 Million in Bayer Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2621064004","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621064004?lang=en_us&edition=fundamental","pubTime":"2026-03-24 20:22","pubTimestamp":1774354920,"startTime":"0","endTime":"0","summary":"Investment firm Inclusive Capital, founded by activist investor Jeff Ubben, is selling a stake in Bayer for 318 million euros .Inclusive Capital sold around 8.5 million shares in the German agricultural and pharmaceutical company, representing a 0.9% stake, according to terms of the sale seen by Dow Jones Newswires. The shares were sold at 37.45 euros each, according to the deal terms. Bayer's shares closed at 38.47 euros on Monday.Shares in Bayer were down 2.1% at 37.67 euros in European midday trading Tuesday, having fallen as much as 3.7% earlier. The stock is up 56% over the past year.Ubben's firm took a stake in Bayer in early 2023 and pushed the company to hire an external candidate as its chief executive.Bayer appointed Ubben to its supervisory board in 2024 with a mandate until 2028, citing his experience in financial and capital markets.The Wall Street Journal reported in 2023 that Ubben was shutting down his social investing-focused firm, Inclusive Capital Partners, and that ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Jeff Ubben's Inclusive Capital Sells $369 Million in Bayer Stock","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAYRY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619461137","title":"Bayer Edging Closer to Litigation Resolution -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2619461137","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619461137?lang=en_us&edition=fundamental","pubTime":"2026-03-16 22:28","pubTimestamp":1773671280,"startTime":"0","endTime":"0","summary":"1428 GMT - The latest developments in Bayer's litigation saga over its Roundup weedkiller support a potential resolution, analysts at UBS say in a research note. The German agricultural and pharmaceutical group has received preliminary approval for its proposed settlement, which is positive, UBS says. An agreement would remove potential risk for the shares and provide closure on the litigation, the analysts say. Some investors are worried about a motion filed in a Missouri court, but even in a worst-case scenario Bayer's shares can't fall much more from current levels, the analysts say. UBS raises its recommendation on Bayer to buy from neutral, lifting its target price to 52 euros from 48 euros. Shares rise 3.9% to 40.15 euros. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618929388","title":"Bayer price target lowered to EUR 53 from EUR 55 at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2618929388","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618929388?lang=en_us&edition=fundamental","pubTime":"2026-03-11 23:15","pubTimestamp":1773242139,"startTime":"0","endTime":"0","summary":"Morgan Stanley lowered the firm’s price target on Bayer (BAYRY) to EUR 53 from EUR 55 and keeps an Overweight rating on the shares. Published first...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-price-target-lowered-to-eur-53-from-eur-55-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-price-target-lowered-to-eur-53-from-eur-55-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0106831901.USD","LU1668664300.SGD","LU0314104364.USD","LU0912757837.SGD","IE00BZ1G4Q59.USD","LU2111349929.HKD","LU0234570918.USD","LU1244550577.SGD","LU1720051017.SGD","LU1074936037.SGD","LU0267386448.USD","BK4585","LU0795875086.SGD","BAYRY","LU2133065610.SGD","LU1989772923.USD","LU2089284900.SGD","LU2271345857.HKD","BK4127","LU0971096721.USD","LU1548497426.USD","LU1732800096.USD","LU1989772840.SGD","LU2023251221.USD","LU0882574139.USD","LU0557290698.USD","BK4516","LU1732799900.SGD","LU1720051108.HKD","LU0795875169.SGD","LU0528227936.USD","LU2357305700.SGD","LU0158827948.USD","LU0106261372.USD","LU1162221912.USD","LU0225283273.USD","LU1363072403.SGD","LU2347655156.SGD","LU0006306889.USD","BK4581","BK4007","BK4534","BK4588","LU0320765646.SGD","LU0098860793.USD","LU1244550221.USD","LU2028103732.USD","IE00BKVL7J92.USD","LU1244550494.USD","LU0158827781.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617515213","title":"Bayer's Roundup Settlement Isn't a Done Deal Yet -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2617515213","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617515213?lang=en_us&edition=fundamental","pubTime":"2026-03-05 15:03","pubTimestamp":1772694180,"startTime":"0","endTime":"0","summary":"0702 GMT - Bayer's proposed $7.25 billion U.S. settlement over its Roundup weedkiller got preliminary approval from a Missouri court, but full acceptance from plaintiffs isn't yet a done deal, Berenberg's Sebastian Bray says in a research note. Plaintiffs now have until June 4 to opt out of the settlement or file objections ahead of a fairness hearing scheduled for July 9. Separately, the U.S. Supreme Court is expected to decide on a Roundup case brought by Bayer by the end of its session in June. The deadline for plaintiffs on the settlement might fall on either side of the Supreme Court ruling, Berenberg's Bray says. \"The incentives to accept the settlement upfront, as opposed to waiting for a ruling before deciding, may therefore not be completely clear-cut,\" the analyst says. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAYRY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617564159","title":"Dow Jones Top Company Headlines at 5 PM ET: Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback as AI Demand Climbs | Ford ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2617564159","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617564159?lang=en_us&edition=fundamental","pubTime":"2026-03-05 06:00","pubTimestamp":1772661600,"startTime":"0","endTime":"0","summary":"Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback as AI Demand Climbs. The semiconductor and software maker's revenue rose 29% as AI demand continued to drive sales.Ford Posts Lower U.S. Sales in February on Declines in Electric, Hybrid Vehicles. The carmaker said it sold a total of 149,962 vehicles in the U.S. last month, down 5.5% from the prior-year period.The ticket exchange platform posted a loss of $535.3 million that included a $492.9 million nonrecurring, noncash provision for income taxes during the quarter.American Eagle Fourth-Quarter Sales Rise on Aerie Growth. CEO Jay Schottenstein said the company saw higher demand in the quarter due to new collections and marketing campaigns, helping it build on improved trends that began last summer.Apple Uses Low Prices to Attack Rivals During Memory-Chip Crunch. Leveraging its supply-chain might, the iPhone giant is making a play for more share in cheaper phone and laptop categories.Okta Expects Revenue Growth to Slow in New ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"c247554e81170321621deb3db618021f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823434583.USD","LU1548497426.USD","LU2471134952.CNY","SG9999002224.SGD","LU2756315664.SGD","LU1629891620.HKD","LU0784385840.USD","LU0472753341.HKD","IE00B3PB1722.GBP","LU2471134879.HKD","LU1366333091.USD","LU0949170772.SGD","LU0417517546.SGD","AVGG","LU0466842654.USD","LU1242518931.SGD","LU2750360641.GBP","IE00BN29S564.USD","LU0187121727.USD","LU0345769128.USD","LU0476273544.USD","LU2471134796.USD","LU0154236417.USD","LU0198837287.USD","IE0034235303.USD","LU2242649171.HKD","LU0965509283.SGD","LU0642271901.SGD","LU2458330243.SGD","LU0289961442.SGD","IE0004445239.USD","LU2462157665.USD","LU2764263039.SGD","LU2361045086.USD","LU0345770993.USD","LU0061474960.USD","LU2211815571.USD","LU0787776722.HKD","LU0353189763.USD","BK4515","LU0786609619.USD","LU2237443895.HKD","LU1778281490.HKD","LU2420271590.USD","LU0124676726.USD","LU1280957306.USD","LU2168563687.JPY","LU2242650005.HKD","LU2041044095.USD","LU1712237335.SGD","BAYRY","LU1815336760.USD","LU2360106780.USD","LU1316542783.SGD","IE00BJJMRX11.SGD","SG9999011175.SGD","LU0345770308.USD","LU0795875086.SGD","LU0683600562.USD","BK4566","LU1366192091.USD","LU2430703178.SGD","IE0009356076.USD","SG9999004303.SGD","SGXZ99366536.SGD","LU2360032135.SGD","LU0353189680.USD","LU1934455194.USD","LU0210536198.USD","LU1691799644.USD","LU2403377893.USD","IE00BN8TJ469.HKD","LU0203345920.USD","LU0689626769.HKD","LU1935043023.USD","LU0056508442.USD","LU1815333072.USD","IE00BKDWB100.SGD","IE00BVYPNV92.GBP","BK4585","LU0985320562.USD","IE00BK4W5L77.USD","LU0203202063.USD","LU0949170426.SGD","LU2089985449.USD","IE0034235188.USD","LU2272731865.HKD","IE00BZ9MQY76.HKD","LU0861579265.USD","LU1037948541.HKD","LU0256863902.USD","BK4512","IE00BKVL7J92.USD","LU2168564495.EUR","LU2236285917.USD","LU0965508806.USD","LU0820562030.AUD","IE00BGHQDM52.EUR","LU0210528500.USD","LU0345768153.USD","LU2720916845.USD","LU2750360997.AUD","LU2322448957.HKD","FRDU","LU2361044949.HKD","SG9999015986.USD","BK4588","LU1551013342.USD","LU1069344957.HKD","LU2473716301.USD","LU1934455277.USD","LU0097036916.USD","SG9999015952.SGD","LU1935042991.SGD","LU0444973449.USD","SG9999001424.SGD","BK4141","LU1935042215.USD","LU2592432038.USD","IE00BDGV0183.EUR","LU0081259029.USD","LU0661504455.SGD","IE00BQXX3D17.EUR","LU2764262908.HKD","LU1868837300.USD","LU1064131342.USD","LU0106261372.USD","LU1935042488.USD","LU1992135472.HKD","LU2458330169.SGD","IE00BJLML261.HKD","LU0011850046.USD","LU0348723411.USD","LU2211814178.USD","LU0210533765.USD","LU2931357623.SGD","LU0320765059.SGD","LU2471134523.USD","IE00BMPRXN33.USD","LU2065170008.USD","LU1670628061.USD","LU1934455863.HKD","IE0004445015.USD","BK4533","LU0784384876.USD","LU1242518857.USD","IE00BWXC8680.SGD","IE00BKPKM429.USD","LU1670627923.USD","SG9999003800.SGD","LU2298321311.HKD","LU1917777945.USD","LU0157215616.USD","LU2244417387.USD","LU1732800096.USD","LU1852331112.SGD","LU0354030511.USD","LU2505996509.AUD","LU2087625088.SGD","AVS","LU1868836914.USD","BK4099","LU1244550577.SGD","LU2023250504.SGD","LU2264538146.SGD","IE00B19Z9P08.USD","IE00BZ1G4Q59.USD","IE0005OL40V9.USD","IE00B7KXQ091.USD","LU0511384066.AUD","LU2860962120.EUR","LU2237957811.SGD","LU2543165471.USD","BK4555","AVGX","LU2456880835.USD","LU1551013425.SGD","LU1035775433.USD","LU0640476718.USD","LU0354030438.USD","LU2463028550.USD","LU1670710661.SGD","IE00BJTD4N35.SGD","LU2487616109.SGD","LU1244550494.USD","LU0082616367.USD","IE00BBT3K403.USD","LU2168564065.EUR","LU1992135399.USD","LU0256863811.USD","LU2347655156.SGD","LU1868836757.USD","LU2461242641.AUD","LU2417539215.USD","LU0979878070.USD","BF.B","LU0444971666.USD","LU2322448791.USD","IE00B5949003.HKD","LU2108987350.USD","LU0238689110.USD","LU0965509101.SGD","LU2355687059.USD","BK4581","LU1127390331.HKD","LU0225283273.USD","LU1244550221.USD","OKTA","IE00B775H168.HKD","LU2125154935.USD","LU1988902786.USD","LU0079474960.USD","LU0274383776.USD","LU2237438978.USD","LU2265009873.SGD","LU2430703095.HKD","LU0964807845.USD","LU2063271972.USD","LU0320765646.SGD","IE00BGHQF631.EUR","LU1914381329.SGD","LU1720051017.SGD","LU0672654240.SGD","LU0719512351.SGD","LU0053666078.USD","LU0109392836.USD","BK4144","LU0096362180.USD","IE0001KFT4U8.USD","IE00BJJMRY28.SGD","BK4554","LU0127658192.USD","LU2125154778.USD","LU2896262040.SGD","IE00BMCWC346.EUR","LU0109391861.USD","LU1037948897.HKD","LU0048584097.USD","LU1935043536.SGD","LU0820561818.USD","LU0234572021.USD","BK4543","LU2361044865.SGD","AEO","IE00BJTD4V19.USD","LU0289739343.SGD","LU0234570918.USD","LU1162221912.USD","LU0553294199.USD","LU2357305700.SGD","SGXZ23171101.USD","LU0942090050.USD","IE00BFSS7M15.SGD","LU1145028129.USD","IE00B3S45H60.SGD","BK4551","LU0784383803.USD","LU1989764748.USD","BK4590","BK4605","LU1323610961.USD","LU2746668461.USD","IE00B42XCP33.USD","SGXZ51526630.SGD","LU1804176565.USD","BK4575","LU1003077747.HKD","LU2065169927.USD","IE00BLSP4239.USD","LU2272731782.SGD","BK4516","LU0057025933.USD","LU0203201768.USD","LU0957791311.USD","LU2213496289.HKD","LU1670711123.USD","LU2023250843.SGD","LU2237443549.SGD","LU1803068979.SGD","BK4612","LU2756315318.SGD","IE00BVYPNQ40.USD","LU0708995401.HKD","LU0784385170.HKD","LU2023250330.USD","IE00BVYPNP33.GBP","LU0251132253.USD","LU2250418816.HKD","LU2279689827.SGD","LU1623119135.USD","LU1670710588.SGD","LU2430703251.USD","LU0215105999.USD","LU0957808578.USD","LU1868837136.USD","LU0096364046.USD","SG9999001440.SGD","LU0061475181.USD","LU0912757837.SGD","SGXZ81514606.USD","LU1232071149.USD","LU1674673428.USD","LU0889565833.HKD","LU0738911758.USD","LU2054465674.USD","LU2168564149.EUR","LU2272731600.USD","LU0726765562.USD","LU2237443465.HKD","LU2237443382.USD","LU0868494708.USD","LU1642822529.SGD","LU1732799900.SGD","AVGW","AVL","LU2237957902.USD","LU2286300806.USD","LU0795875169.SGD","LU0345769631.USD","IE00B894F039.SGD","IE00BFSS8Q28.SGD","LU1267930730.SGD","LU2237443978.SGD","IE00BMPRXR70.SGD","IE00B4JS1V06.HKD","LU1989764664.SGD","SG9999015945.SGD","LU2746668974.SGD","LU0345768740.USD","AVGU","LU2168564222.USD","LU2505996681.GBP","IE00BVYPNW00.USD","LU1814569148.SGD","IE00B1XK9C88.USD","LU2602419157.SGD","IE00B19Z9Z06.USD","LU0820561909.HKD","LU2065171311.SGD","LU2360108059.USD","IE00BMPRXQ63.HKD","LU0823434740.USD","LU1670711040.USD","F","LU0316494557.USD","SG9999015978.USD","IE00BLSP4452.SGD","LU0006306889.USD","ADDYY","BK4561","BK4574","LU2764263203.CNY","SG9999002232.USD","LU0170899867.USD","LU2106854487.HKD","LU0545039389.USD","LU2065171402.SGD","LU1720051108.HKD","IE00BQXX3F31.USD","LU0203347892.USD","LU2133065610.SGD","LU0943347566.SGD","IE00BK4W5M84.HKD","LU1301847155.USD","LU2092937221.SGD","IE00B1BXHZ80.USD","LU0323591593.USD","LU2347655073.USD","IE00BYV24P56.USD","LU0069063385.USD","IE00B775SV38.USD","LU1674673691.USD","LU2247934214.USD","BK4598","IE00BQXX3C00.GBP","LU0080751232.USD","LU1868836591.USD","LU2237443622.USD","AVGO","LU0965509010.AUD","LU0689472784.USD","LU1153585028.USD","FRDD","LU0868494617.USD","LU2083900584.USD","LU1974910355.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2617552443","title":"Court preliminary approves Bayer’s Roundup settlement, Bloomberg says","url":"https://stock-news.laohu8.com/highlight/detail?id=2617552443","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617552443?lang=en_us&edition=fundamental","pubTime":"2026-03-05 00:35","pubTimestamp":1772642136,"startTime":"0","endTime":"0","summary":"The Judicial Circuit Court for the City of St. Louis granted preliminary approval of Bayer’s (BAYRY) Roundup $7.25B class-action settlement, accord...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/court-preliminary-approves-bayers-roundup-settlement-bloomberg-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/court-preliminary-approves-bayers-roundup-settlement-bloomberg-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616554334","title":"Bayer Expects Farmers to Plant Less Corn, More Soybeans After Fertilizer Price Spike -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2616554334","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616554334?lang=en_us&edition=fundamental","pubTime":"2026-03-04 23:41","pubTimestamp":1772638860,"startTime":"0","endTime":"0","summary":"1041 ET - Rising fertilizer prices from the Iran conflict are expected to prompt more American farmers to plant soybeans this spring instead of corn, executives at Bayer say. The recent halt in shipping through the Strait of Hormuz has jolted fertilizer markets, sending prices higher at a time when farmers are already struggling to make a profit. The Strait accounts for nearly 25% of global trade in nitrogen fertilizer, according to analysts at StoneX. Corn crops typically use more fertilizer than soybeans. Bayer expects more farmers to shift to soybeans to cut costs, which will hurt the company's bottom line because the products it sells farmers for growing corn are more profitable than those for soybeans. Bayer is off 4%. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAYRY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616555374","title":"Bayer gets FDA clearance of Medrad MRXperion Magnetic Resonance Injection System","url":"https://stock-news.laohu8.com/highlight/detail?id=2616555374","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616555374?lang=en_us&edition=fundamental","pubTime":"2026-03-04 21:35","pubTimestamp":1772631344,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) announced that the FDA granted 510(k) clearance for expanded capabilities of its Medrad MRXperion Magnetic Resonance Injection System...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-gets-fda-clearance-of-medrad-mrxperion-magnetic-resonance-injection-system-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-gets-fda-clearance-of-medrad-mrxperion-magnetic-resonance-injection-system-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BAYRY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616530743","title":"Bayer Sees Pharma Business Turning a Corner -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2616530743","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616530743?lang=en_us&edition=fundamental","pubTime":"2026-03-04 20:52","pubTimestamp":1772628720,"startTime":"0","endTime":"0","summary":"1252 GMT - Bayer sees its pharmaceutical business at a turning point, with recent drug launches expected to balance out a hit from patent expirations this year, divisional head Stefan Oelrich says in a call with reporters. \"We have now entered the last year of what we are calling our resilience phase,\" Oelrich says. Sales of Nubeqa cancer drug and Kerendia kidney medicine are expected to grow about 50% this year at constant currency, he says. Overall, the German company expects full-year sales at its pharma division to be flat or grow up to 3% at constant currency, with a stronger performance in the second half, before returning to mid single percentage digit growth in 2027, Oelrich says. Shares fall 3.6%. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAYRY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616530912","title":"Bayer Expects Consumer Sales to Remain Under Pressure in U.S., China -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2616530912","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616530912?lang=en_us&edition=fundamental","pubTime":"2026-03-04 20:41","pubTimestamp":1772628060,"startTime":"0","endTime":"0","summary":"1240 GMT - Bayer's consumer-health sales were held back by weakness in the U.S. and China last year and the German company expects challenges in the unit's two biggest markets to continue for now, division head Julio Triana says in a call with reporters. \"In the near term, we expect continued volatility in China and the U.S., with performance likely to contract,\" Triana says. \"Slowing growth and market volatility there could heavily influence our results.\" Bayer forecasts sales at its consumer-health division to be flat or grow by up to 4% this year when adjusted for currency and portfolio changes. A pick-up in consumer spending in the U.S. and China could leave the higher end of the guidance range within reach, Triana says. Shares fall 3.7%. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAYRY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616537379","title":"Bayer Expects Challenging Agriculture Market in 2026 -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2616537379","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616537379?lang=en_us&edition=fundamental","pubTime":"2026-03-04 20:13","pubTimestamp":1772626380,"startTime":"0","endTime":"0","summary":"1213 GMT - Bayer anticipates a tough agriculture market in 2026, but expects benefits from a restructuring of its agricultural business to result in improvements in the unit's top and bottom lines, division head Rodrigo Santos says. \"We expect ag market fundamentals to remain challenging and project below-average market growth,\" Santos says in a call with reporters. Bayer guided for sales at its agricultural business to be flat or rise by up to 3% excluding currency changes in 2026. The division's Ebitda before special items margin is expected to rise to between 20% and 22% at constant currency, from 19% in 2025. Santos attributes the expected improvement to cost discipline, as well as to pricing and sales mix benefits from its portfolio streamlining. Bayer shares fall 3.4%. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616539481","title":"Bayer Q4 Adj. EPS $0.18 Down From $0.28 YoY, Sales $13.316B Up From $12.518B YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2616539481","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616539481?lang=en_us&edition=fundamental","pubTime":"2026-03-04 18:41","pubTimestamp":1772620874,"startTime":"0","endTime":"0","summary":"Bayer (OTC:BAYRY) reported quarterly earnings of $0.18 per share. This is a 35.71 percent decrease over earnings of $0.28 per share from the same period last year.  The company reported $13.316 billion in sales this","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51028175/bayer-q4-adj-eps-0-18-down-from-0-28-yoy-sales-13-316b-up-from-12-518b-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616801425","title":"Bayer Beats Expectations, But Currency Headwinds Cloud Outlook -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2616801425","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616801425?lang=en_us&edition=fundamental","pubTime":"2026-03-04 16:32","pubTimestamp":1772613120,"startTime":"0","endTime":"0","summary":"0832 GMT - Bayer's fourth-quarter results came in better than expected, but its 2026 outlook points to cuts to consensus estimates due to foreign-exchange rates, analysts at J.P. Morgan say in a research note. The German agricultural and pharmaceutical group reported quarterly sales that beat consensus estimates by 1%, mainly thanks to its agricultural business, the analysts say. Adjusted earnings beat consensus forecasts by 3%, driven by both pharma and agriculture, they add. Bayer's outlook implies a cut of around 3% to consensus estimates on 2026 adjusted Ebitda, largely related to currencies, according to JPM. Nevertheless, investors seem more focused on the outcome of Bayer's proposed Roundup settlement and the U.S. Supreme Court decision than on results, the analysts say. Shares fall 3.4%. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":64,"code":"91000000","status":"200"}]}}